< 1 minute read
Dec. 20, 2021
Compound 1: a RET inhibitor
compound 1
oral RET kinase inhibitor effective in tumor xenograft model from scaffold hopping & optimization ACS Medicinal Chemistry Letters Novartis Genomics Institute
oral RET kinase inhibitor effective in tumor xenograft model from scaffold hopping & optimization ACS Medicinal Chemistry Letters Novartis Genomics Institute